Search results
Harry Crijns
Author
AHA 23: The ORFAN Study
Author(s):
Charalambos Antoniades
Added:
4 months ago
Video
Author(s):
Martha Gulati
Added:
1 year ago
ESC Congress 2022 — In this short and practice-focused review, Dr Martha Gulati, Associate Director of the Barbra Streisand Women Heart Center and Director of CVD Prevention(Cedars-Sinai Medical Center, US) shares some her thoughts on the top 3 hot line trials.
Trials covered in detail include:
00:27: TIME:The Treatment in Morning versus Evening
01:57: SECURE:A polypill strategy in secondary…
View more
Corrado Tamburino
Job title: Professor and Chief of Cardiothoracic, Transplantation and Vascular Surgery Department
Author
Author(s):
Ovidiu Chioncel
,
Sean P Collins
,
Stephen J Greene
,
et al
Added:
3 years ago
Hospitalisation is a critical event in the clinical course of heart failure (HF) and despite relatively rapid relief of symptoms, hospitalisation is followed by an increased risk of death and re-hospitalisation.1 While performance measures have been developed in the last few years with the intent of improving post-discharge outcomes, post-discharge mortality rates remain unchanged or have…
View more
Author(s):
Tonje Thorvaldsen
,
Lars H Lund
Added:
3 years ago
Heart failure (HF) is associated with poor quality of life, high risk of death and is the leading cause of hospitalisation.1 With an ageing population and improved care for cardiovascular diseases, the prevalence of HF is increasing. Despite advances in HF therapies, 1–10% of the population with HF progress to an advanced stage of the disease.2,3 In the US, an estimated 250,000–300,000 patients…
View more
Author(s):
Marco Metra
,
Elisabetta Dinatolo
,
Nicolò Dasseni
Added:
3 years ago
Despite improvements in treatment, heart failure (HF) continues to have a progressive clinical course characterised by worsening of cardiac function and clinical condition, leading to a stage of advanced chronic HF. At this stage, the clinical picture is characterised by severe symptoms, frequent episodes of decompensation, poor quality of life and poor survival. Evidence-based medical treatments…
View more
Foreword
Author(s):
Andrew JS Coats
,
Giuseppe Rosano
Added:
3 years ago
Article
Author(s):
Jackson J Liang
,
David J Callans
Added:
3 years ago
As the population ages, the incidence of both AF and heart failure (HF) will continue to increase. By the year 2030, there will be an estimated >12 million patients with AF and >8 million patients with HF.1,2 A significant proportion of patients with HF have reduced (<50%) left ventricular ejection fraction (heart failure with reduced ejection fraction, HFrEF) and the coexistance of AF…
View more
Author(s):
Mattia Arrigo
,
Petra Nijst
,
Alain Rudiger
Added:
3 years ago
Heart failure is a clinical syndrome induced by cardiac abnormalities resulting in reduced cardiac output and/or elevated intra-cardiac end-diastolic pressures and causing symptoms that are often accompanied by typical physical signs.1 Demographic changes, improved treatment of several acute cardiac disorders, such myocardial infarction, arrhythmia and congenital heart disease, and increased long…
View more